In Silico Drug Discovery Platform
WuXi AppTec offers a comprehensive platform of in silico drug discovery services to accelerate the process of hit finding and hit-to-lead optimization. We provide access to virtual chemical spaces built from our library of novel drug-like scaffolds, to support virtual screening and structure-based virtual screening (SBVS).
Advances in ML-empowered virtual screening allows project teams to access a rapidly expanding and diverse chemical space, to discover potent novel molecules. By combining experimental data (from techniques such as DEL and ASMS) with computational predictions, our experts can deliver results with enhanced predictivity.

Flyer_In Silico Drug Discovery Platform
Related Content
Hit validation is a crucial step in drug discovery based on DNA-encoded libraries (DEL). Rapid and accurate resynthesis of compounds,...
VIEW RESOURCEThe ATP-adenosine pathway plays a crucial role in regulating immune responses, including those involved in combating tumors. CD39 is an...
VIEW RESOURCE